{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:43:18Z","timestamp":1790970198872,"version":"4.1.0"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T00:00:00Z","timestamp":1438819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0135041","type":"journal-article","created":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T18:07:00Z","timestamp":1438884420000},"page":"e0135041","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Evidence of Subclinical mtDNA Alterations in HIV-Infected Pregnant Women Receiving Combination Antiretroviral Therapy Compared to HIV-Negative Pregnant Women"],"prefix":"10.1371","volume":"10","author":[{"given":"Deborah M.","family":"Money","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn J.","family":"Maan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Chaworth-Musters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabelle","family":"Gadawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie E.","family":"van Schalkwyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Burdge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianne Y. K.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Lohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne C. F.","family":"C\u00f4t\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Oak Tree Clinic Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,8,6]]},"reference":[{"key":"ref1","unstructured":"World Health Organization. HIV\/AIDS Fact Sheet. 2014; Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/mediacentre\/factsheets\/fs360\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/mediacentre\/factsheets\/fs360\/en\/<\/ext-link>."},{"issue":"Suppl B","key":"ref2","first-page":"S79","article-title":"Prevention of mother-to-child transmission of HIV-1 in Africa","volume":"11","author":"SZ Wiktor","year":"1997","journal-title":"AIDS"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJM199611283352201","article-title":"Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group","volume":"335","author":"RS Sperling","year":"1996","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1086\/318530","article-title":"Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads &lt;1000 copies\/ml","volume":"183","author":"JP Ioannidis","year":"2001","journal-title":"J Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/00042560-200204150-00009","article-title":"Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission","volume":"29","author":"ER Cooper","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref6","first-page":"797","article-title":"Human immunodeficiency virus infection in pregnancy","volume":"101","author":"H Minkoff","year":"2003","journal-title":"Obstet Gynecol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1086\/427287","article-title":"Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy","volume":"40","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1258\/095646207782212360","article-title":"Antiretroviral therapy in pregnancy: local practice in East London, UK","volume":"18","author":"KM Forbes","year":"2007","journal-title":"Int J STD AIDS"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/QAD.0b013e328350995c","article-title":"A national review of vertical HIV transmission","volume":"26","author":"JC Forbes","year":"2012","journal-title":"AIDS"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0140-6736(98)08084-2","article-title":"Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1086\/591253","article-title":"Perinatal exposure to antiretroviral therapy is associated with increased bloodmitochondrial DNA levels and decreased mitochondrial gene expression in infants","volume":"198","author":"HC C\u00f4t\u00e9","year":"2008","journal-title":"J Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3851\/IMP2473","article-title":"Atazanavir pharmacokinetics, efficacy and safety in pregnancy: a systematic review","volume":"18","author":"T Eley","year":"2013","journal-title":"Antiviral Therapy"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1310\/hct0902-126","article-title":"Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV-infected mothers on antiretroviral therapy","volume":"9","author":"GA McComsey","year":"2008","journal-title":"HIV Clin Trials"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1468-1293.2011.00945.x","article-title":"Effects of in utero antiretroviral exposure on mitochonial DNA levels, mitochondrial function and oxidative stress","volume":"13","author":"AC Ross","year":"2012","journal-title":"HIV Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e1189","DOI":"10.1542\/peds.2008-2771","article-title":"Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women","volume":"124","author":"GM Aldrovandi","year":"2009","journal-title":"Pediatrics"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3851\/IMP1613","article-title":"Antiretroviral therapy in pregnancy: balancing the risk of preterm delivery with prevention of mother-to-child HIV transmission","volume":"15","author":"CL Townsend","year":"2010","journal-title":"Antivir Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/00002030-199814000-00004","article-title":"Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway","volume":"12","author":"K Brinkman","year":"2008","journal-title":"AIDS"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/COH.0b013e3283632b88","article-title":"Safety of antiretroviral drugs in pregnancy and breastfeeding for mother and child","volume":"8","author":"ML Newell","year":"2013","journal-title":"Curr Opin HIV AIDS"},{"issue":"Suppl","key":"ref19","first-page":"2M3","article-title":"Possible ways nucleoside analogues can affect mitochondrial DNA content and gene expression during HIV therapy","volume":"10","author":"HC C\u00f4t\u00e9","year":"2005","journal-title":"Antivir Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/COH.0b013e3281df3410","article-title":"Mechanisms of antiretroviral therapy-induced mitochondrial dysfunction","volume":"2","author":"HC C\u00f4t\u00e9","year":"2007","journal-title":"Curr Opin HIV AIDS"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.tips.2011.07.007","article-title":"Mitochondrial interference by anti-HIV drugs: mechanisms beyond Pol-gamma inhibition","volume":"32","author":"N Apostolova","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nm0595-417","article-title":"Mitochondrial toxicity of antiviral drugs","volume":"1","author":"W Lewis","year":"1995","journal-title":"Nat Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"23616","DOI":"10.1074\/jbc.M101114200","article-title":"Differential incorporation and removal of antiviral deoxynucleotides by human DNA polymerase gamma","volume":"276","author":"SE Lim","year":"2001","journal-title":"J Biol Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1128\/AAC.38.12.2743","article-title":"Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis","volume":"38","author":"JL Martin","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa012035","article-title":"Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients","volume":"346","author":"HC C\u00f4t\u00e9","year":"2002","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/labinvest.3780288","article-title":"Mitochondrial dna depletion, oxidative stress, and mutation: mechanisms of dysfunction from nucleoside reverse transcriptase inhibitors","volume":"81","author":"W Lewis","year":"2001","journal-title":"Lab Invest"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000134943","article-title":"Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy","volume":"82","author":"ER Scruggs","year":"2008","journal-title":"Pharmacology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/em.20433","article-title":"Mutational analysis of the mitochondrial tRNA genes and flanking regions in umbilical cord tissue from uninfected infants receiving AZT-based therapies for prophylaxis of HIV-1","volume":"50","author":"SM Torres","year":"2009","journal-title":"Environ Mol Mutagen"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/ng.863","article-title":"Mitochondrial aging is accelerated by anti-retroviral therapy through the clonal expansion of mtDNA mutations","volume":"43","author":"BA Payne","year":"2011","journal-title":"Nat Genet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/QAD.0b013e32835142eb","article-title":"Blood mitochondrial DNA mutations in HIV-infected women and their infants exposed to HAART during pregnancy","volume":"26","author":"MH Jitratkosol","year":"2012","journal-title":"AIDS"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/QAD.0000000000000486","article-title":"Mitochondrial disturbances in HIV pregnancies","volume":"29","author":"C Mor\u00e9n","year":"2015","journal-title":"AIDS"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1097\/00002030-200012220-00013","article-title":"Combination antiretroviral therapy and duration of pregnancy","volume":"14","year":"2000","journal-title":"AIDS"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJMoa991159","article-title":"Antiretroviral therapy during pregnancy and the risk of an adverse outcome","volume":"346","author":"RE Tuomala","year":"2002","journal-title":"N Engl J Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/01.qai.0000139398.38236.4d","article-title":"Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy","volume":"38","author":"RE Tuomala","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1097\/00002030-200411190-00019","article-title":"Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe","volume":"18","author":"C Thorne","year":"2004","journal-title":"AIDS"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1086\/503045","article-title":"Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth?","volume":"193","author":"AM Cotter","year":"2006","journal-title":"J Infect Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1471-0528.2006.01183.x","article-title":"The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery","volume":"114","author":"K Boer","year":"2007","journal-title":"BJOG"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1097\/01.aids.0000253362.01696.9d","article-title":"Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth","volume":"20","author":"EG Szyld","year":"2006","journal-title":"AIDS"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1086\/651232","article-title":"Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy","volume":"201","author":"K Patel","year":"2010","journal-title":"J Infect Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/infdis\/jir307","article-title":"Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy","volume":"204","author":"KM Powis","year":"2011","journal-title":"J Infect Dis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1515\/jpm.2010.052","article-title":"Pregnancy and delivery outcomes of HIV infected women in Switzerland 2003\u20132008","volume":"38","author":"K Aebi-Popp","year":"2010","journal-title":"J Perinat Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/QAD.0b013e32834db300","article-title":"Association of HIV infection with spontaneous and iatrogenic preterm delivery: effect of HAART","volume":"26","author":"M Lopez","year":"2012","journal-title":"AIDS"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/QAD.0b013e32834f3232","article-title":"Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn","volume":"26","author":"S Hernandez","year":"2012","journal-title":"AIDS"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrg1606","article-title":"Mitochondrial DNA mutations in human disease","volume":"6","author":"R Taylor","year":"2005","journal-title":"Nat Rev Genet"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1083\/jcb.201010024","article-title":"Mitochondrial DNA mutations in disease and aging","volume":"193","author":"C Park","year":"2011","journal-title":"J Cell Biol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/path.3028","article-title":"Mitochondrial DNA and disease","volume":"226","author":"L Greaves","year":"2012","journal-title":"J Pathol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0140-6736(99)07219-0","article-title":"Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues","volume":"354","author":"S Blanche","year":"1999","journal-title":"Lancet"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1097\/00002030-200308150-00006","article-title":"Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort","volume":"17","author":"B Barret","year":"2003","journal-title":"AIDS"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/00002030-200404300-00009","article-title":"Mitochondrial damage and DNA depletion in cord blood and umbilical cord from infants exposed in utero to Combivir","volume":"18","author":"RL Divi","year":"2004","journal-title":"AIDS"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/00126334-200304010-00004","article-title":"Placenta and cord blood mitochondrial DNA toxicity in HIV-infected women receiving nucleoside reverse transcriptase inhibitors during pregnancy","volume":"33","author":"B Shiramizu","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/135965350901400309","article-title":"Mitochondrial toxicity in HIV type-1-exposed pregnancies in the era of highly active antiretroviral therapy","volume":"14","author":"A Gingelmaier","year":"2009","journal-title":"Antivir Ther"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00126334-200306010-00010","article-title":"Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers","volume":"33","author":"MC Poirier","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"e41637","DOI":"10.1371\/journal.pone.0041637","article-title":"Zidovudine Exposure in HIV-1 Infected Tanzanian Women Increases Mitochondrial DNA Levels in Placenta and Umbilical Cords","volume":"7","author":"A Kunz","year":"2012","journal-title":"PLoS One"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/bimj.200810425","article-title":"Simultaneous inference in general parametric models","volume":"50","author":"T Hothorn","year":"2008","journal-title":"Biom J"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/joim.12055","article-title":"The role of mitochondrial DNA mutations and free radicals in disease and ageing","volume":"273","author":"M Lagouge","year":"2013","journal-title":"J Intern Med"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/hmg\/dds435","article-title":"Universal heteroplasmy of human mitochondrial DNA","volume":"22","author":"BA Payne","year":"2013","journal-title":"Hum Mol Genet"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"e59514","DOI":"10.1371\/journal.pone.0059514","article-title":"HIV protease inhibitors disrupt lipid metabolism by activating endoplasmic reticulum stress and inhibiting autophagy activity in adipocytes","volume":"8","author":"BS Zha","year":"2013","journal-title":"PLoS One"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/hep.24459","article-title":"Compromising mitochondrial function with the antiretroviral drug efavirenz induces cell survival-promoting autophagy","volume":"54","author":"N Apostolova","year":"2011","journal-title":"Hepatology"},{"key":"ref59","unstructured":"Perinatal Services BC. BC Perinatal Surveillance 2003\/2004 to 2012\/2013. 2014; Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.perinatalservicesbc.ca\/NR\/rdonlyres\/EB1AC307-689C-4E20-A551-86568CBE9FFF\/0\/AnnualIndicators_Residents_BC_2013_14.pdf\" xlink:type=\"simple\">http:\/\/www.perinatalservicesbc.ca\/NR\/rdonlyres\/EB1AC307-689C-4E20-A551-86568CBE9FFF\/0\/AnnualIndicators_Residents_BC_2013_14.pdf<\/ext-link>."},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1086\/429412","article-title":"Infection with HIV-1 induces a decrease in mtDNA","volume":"191","author":"M Casula","year":"2005","journal-title":"J Infect Dis"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1468-1293.2005.00336.x","article-title":"Depletion of mitochondrial DNA copies\/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naive patients","volume":"7","author":"A Maagaard","year":"2006","journal-title":"HIV Med"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/423176","article-title":"Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals","volume":"39","author":"O Miro","year":"2004","journal-title":"Clin Infect Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0135041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T01:22:37Z","timestamp":1653009757000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0135041"}},"subtitle":[],"editor":[{"given":"Dhayendre","family":"Moodley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,6]]},"references-count":62,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0135041","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,6]]}}}